Study Shows Vision, Anatomy Stable With Port System for AMD

Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.

Related Keywords

Iowa ,United States ,Texas ,American ,David Massop ,Genentech Roche ,Charles Wykoff ,American Society Of Retina Specialists ,Novartis ,Regeneron Pharmaceuticals ,Drug Administration ,Blanton Eye Institute ,Wolfe Eye Clinic ,Des Moines ,American Society ,Retina Specialists ,Medscape Medical ,Age Related Macular Degeneration Treatments Trial ,Retina Consultants ,Houston Methodist Hospital ,Presented July ,Retinal Disease ,Exudative Age Related Macular Degeneration ,Xudative Armd ,Anatomy ,Vision Care And Maintenance ,Retina ,Ophthalmologic Trauma ,Phthalmologic Injuries ,Ocular Injury ,Eye Injuries ,Eye ,Vitreous Hemorrhage ,Itreous Bleeding ,Hyphema ,Macular Degeneration ,Ge Related Macular Degeneration Armd ,Sclera ,Visual Acuity ,Vitreous ,Patient Safety ,Rhegmatogenous Retinal Detachment ,Cataracts ,Heal ,